Beam Therapeutics Inc
BEAM
$16.76-0.23 (-1.35%)
Jun 22, 2025, 4:00 PM
Financials
| 52Week High | 35.25 | 52Week Low | 13.53 |
| Beta | 2.23 | Current Ratio Annual | 4.82 |
| Current Ratio Quarterly | 8.81 | Market Cap | 1.69B |
| Net Profit Margin TTM | -609.24 | Operating Margin TTM | -677.47 |
| Price To Book | 1.50 | Price To Sales TTM | 26.51 |
| Quick Ratio Annual | 4.67 | Quick Ratio Quarterly | 8.62 |
| Return On Assets TTM | -30.97 | Return On Equity TTM | -44.24 |
| Return On Investment TTM | -44.24 | Revenue Growth3Y | 7.01 |
| Revenue Growth5Y | 401.62 | Revenue Growth Quarterly Yoy | 0.81 |
| Revenue Growth TTMYoy | -82.38 | Revenue Per Share TTM | 0.72 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 237 | 4 | 0 | 3 | 5 | 2 | 81.93M | $1.97B |
| Mar 31, 2025 | 233 | 38 | 40 | 99 | 46 | 44 | 102.09M | $1.93B |
| Change | 4(2%) | 34(850%) | 40 | 96(3200%) | 41(820%) | 42(2100%) | 20.16M(25%) | $42.30M(2%) |